Evidence map›Paper›PMID 38502145›Full record

ArticleAmerican journal of physiology. Gastrointestinal and liver physiology2024

Binqiang Xu, Yang Fu, Nuoming Yin, Wenfei Qin, Zehua Huang, Wei Xiao, Huizhen Huang, Qixiang Mei, Junjie Fan, Yue Zeng and 1 more

Open access · hybridAbstract read
In one paragraph

Article in American journal of physiology. Gastrointestinal and liver physiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
8.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. A Review on the Molecular Dynamics of EnterotypeInternational journal of molecular sciences · 2026
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Foods (Basel, Switzerland) · 2026
    Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. UncoveringGut microbes · 2025
    Article
  16. Multifaceted Role of Microbiota-Derived Indole-3-Acetic Acid in Human Diseases and Its Potential Clinical Application.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Binqiang XuShanghai Key Laboratory of Pancreatic Diseases, Shanghai JiaoTong University School of Medicine, Shanghai, People's Republic of China.
Yang FuShanghai Key Laboratory of Pancreatic Diseases, Shanghai JiaoTong University School of Medicine, Shanghai, People's Republic of China.
Nuoming YinShanghai Key Laboratory of Pancreatic Diseases, Shanghai JiaoTong University School of Medicine, Shanghai, People's Republic of China.
Wenfei QinShanghai Key Laboratory of Pancreatic Diseases, Shanghai JiaoTong University School of Medicine, Shanghai, People's Republic of China.
Zehua HuangShanghai Key Laboratory of Pancreatic Diseases, Shanghai JiaoTong University School of Medicine, Shanghai, People's Republic of China.
Wei XiaoShanghai Key Laboratory of Pancreatic Diseases, Shanghai JiaoTong University School of Medicine, Shanghai, People's Republic of China.
Huizhen HuangShanghai Key Laboratory of Pancreatic Diseases, Shanghai JiaoTong University School of Medicine, Shanghai, People's Republic of China.
Qixiang MeiShanghai Key Laboratory of Pancreatic Diseases, Shanghai JiaoTong University School of Medicine, Shanghai, People's Republic of China.
Junjie FanDepartment of Gastroenterology, Shanghai General Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, People's Republic of China.
Yue ZengShanghai Key Laboratory of Pancreatic Diseases, Shanghai JiaoTong University School of Medicine, Shanghai, People's Republic of China.ORCID 0000-0003-0284-4955
Chunlan HuangShanghai Key Laboratory of Pancreatic Diseases, Shanghai JiaoTong University School of Medicine, Shanghai, People's Republic of China.ORCID 0009-0005-9243-3501
Shanghai Jiao Tong University · CNUniversity of Shanghai for Science and Technology · CNShanghai Medical College of Fudan University · CN

Funding

MOST | National Natural Science Foundation of China (NSFC) NO. 81970555MOST | National Natural Science Foundation of China (NSFC) NO. 82270671Shanghai Jiao Tong University School of Medicine, Digestive Institute KY-2023-03-02Songjiang Science and Technology Committee 22SJKGGG28
6 · The paper itself

Abstract

Fecal microbiota transplantation (FMT) is a promising therapy for inflammatory bowel disease (IBD) via rectifying gut microbiota. The aim of this study was to identify a mechanism of how specific bacteria-associated immune response contributes to alleviated colitis. Forty donors were divided into high (

Indexed as

Bacteroides thetaiotaomicronColitisFaecalibacterium prausnitziiFecal Microbiota TransplantationGastrointestinal MicrobiomeAdultAnimalsDextran SulfateDisease Models, AnimalFecesFemaleHumansInterleukin-10MaleMiceMice, Inbred C57BLDextran SulfateInterleukin-10Bacteroides thetaiotaomicronFaecalibacterium prausnitziifecal microbiota transplantationgut microbiotainflammatory bowel disease

Identifiers

PMID38502145
PMCPMC11376976
OpenAlexW4392949856

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.